1.A relationship between genetic polymorphisms of CYP2E1 and susceptibility of acute leukemia in Gansu population
Xiue SHI ; Jianwang XU ; Jialing MA ; Hai LIU ; Mingfeng JIA ; Chunxia LIU ; Yaming XI
Cancer Research and Clinic 2010;22(z1):5-7
Objective To study the relationship between genetic polymorphisms of CYP2E1 and the susceptibility of the acute leukemia in Gansu population. Methods The C609T polymorphism of CYP2E1 gene was detected by polymerase chain reaction-ligase detection reaction (PCR-LDR) and 1∶1 matched casecontrol method in 100 healthy persons (control group) and 100 patients with acute leukemia (AL group).Results The C2 allele genotype and C1C2/C2C2 genotype of CYP2E1 gene occurred more frequently in AL group (13.5 % and 22 %, respectively) than those in control group (10.5 % and 19 %, respectively), however,both differences showed no statistical significant. Further stratified analysis, the C1C2/C2C2 genotype of CYP2E1 gene occurred more frequently in AML group (27%) than that in control group (19 %), but difference had no statistical significant, too. The occurrence frequency of the C2 allele genotype and C1C2/C2C2 genotype of CYP2E1 gene showed no significant difference in ALL group and control group (x2=0.446, P =0.504>0.05). Conclusion Genetic polymorphisms of CYP2E1 don't correlated to susceptibility of acute leukemia(AML and ALL) in Gansu population.
2.Efficacy and Safety in Secondary Prevention of Ischemic Stroke with Cilostazol or Aspirin: A Systematic Review
Haixia FENG ; Man YANG ; Huaili JIANG ; Wenzhe HUA ; Junfang HE ; Huixia YAO ; Yabin LI ; Tao XU ; Lianxiu HE ; Xiue SHI ; Jinqiu YUAN ; Yali LIU
Chinese Journal of Rehabilitation Theory and Practice 2010;16(10):961-965
ObjectiveTo review the efficacy and safety in secondary prevention of ischemic stroke with cilostazol or aspirin.Methodswe searched Cochrane Library(the 4th issue, 2009 ), PubMed(1980.1~2009.11), EMBASE(1980.1~2009.11), CBM(1978.1~2009.11), CNKI(1979.1~2009.11) and some other databases, then collected all of the studies describing the outcomes in curing the ischemic stroke after taking cilostazol or aspirin. According to the strict inclusion and exclusion criteria, two reviewers independently selected trials, extracted datas, made cross-checking and methodological quality assessment of the homogeneity studies by using the Cochrane systematic review methods, then made Meta analysis using RevMan 5.0 software.ResultsThis systematic review study included two randomized controlled trials and a cross-over trial, which contained a total of 838 participants. The evidence quality of one of the randomized controlled trials was high, however, the evidence quality of another randomized controlled trial and the cross-over trial was poor. Meta analysis results suggested that the effectiveness of cilostazol and aspirin in the secondary prevention of ischemic stroke performed no significantly statistical difference: primary endpoint(30 d[RR=3.00, 95%CI(0.31,28.70)]; 90 d[RR=1.67, 95%CI(0.40,6.92)]; 180 d[RR=1.25, 95%CI(0.50, 3.13)]; 360 d[RR=0.65, 95%CI(0.33, 1.29)]; 540 d[RR=0.80,95%CI(0.54, 1.18)]); combined endpoint(30 d[RR=4.00, 95%CI(0.45,35.61)]; 90 d [RR=1.75,95%CI(0.52,5.93)]; 180 d[RR=1.00, 95%CI(0.48, 2.07)]; 360 d [RR=0.77, 95%CI(0.45, 1.29)]; 540 d[RR=0.66,95%CI(0.40,1.09)]); the recurrence of ischemic stroke: cilostazol group: RR=0.64, 95%CI(0.31,1.30),aspirin group: RR=0.21, 95%CI(0.04,1.06); PDMP[RR=1.00, 95%CI(0.39, 2.58)]. But in terms of the probability of intracranial hemorrhage ([RR=7.14, 95%CI(0.7,58.33)]) and other safety standards, taking cilostazol performed lower than taking aspirin.ConclusionThe side effects of cilostazol and aspirin in the treatment for ischemic stroke were similar to each other, but in terms of the probability of dizziness, headache, tachycardia and palpitation, taking cilostazol performed higher than taking aspirin, however, taking cilostazol performed lower in the probability of intracranial hemorrhage and other organ hemorrhage than taking aspirin. Since this study included a small amount of studies, in which the evidence quality of one of the randomized controlled trials and the cross-over study was poor, therefore, it would be necessary to make a further validation with lots of high-quality clinical trials.
3.Influencing factors of nursing cognition among caregivers of patients with end-stage renal disease
Ming LI ; Helou HUANG ; Xiue XU ; Ruixue ZHANG
Chinese Journal of Modern Nursing 2022;28(22):3029-3032
Objective:To investigate the status quo of nursing cognition of caregivers of patients with end-stage renal disease based on cognitive adaptation theory and explore its influencing factors.Methods:The convenient sampling method was adopted to select 150 caregivers of patients with end-stage renal disease admitted to Affiliated Hospital of Jining Medical University from June 2018 to June 2020 as the research objects. Guided by cognitive adaptation theory, a questionnaire was designed to investigate the caregivers' cognitive level of end-stage renal disease care. According to the survey results, caregivers were divided into the high cognition group and the low cognition group. Univariate analysis and Logistic regression analysis were used to analyze the influencing factors of cognitive level of caregivers.Results:There were 150 caregivers in this group, 60 of whom had high nursing cognition, accounting for 40%. There were statistically significant differences between the high cognition group and the low cognition group in knowledge training, life meaning score, internal control scale score and benefit discovery score ( P<0.05) . Logistic regression analysis showed that knowledge training, meaning of life, internal sources of control and the discovery of benefits were the influencing factors for the nursing cognition level of patients with end-stage renal disease ( P<0.05) . Conclusions:The nursing cognition level of caregivers of patients with end-stage renal disease is affected by whether they participate in knowledge training, sense of life meaning, internal control psychological control source and benefit discovery.
4.Effect of ICX ? tablets on controlling the pollution of dental unit waterlines
Hua LI ; Yuting NIU ; Wei SUN ; Chunli WANG ; Xiue LI ; Yun DANG ; Qian WANG ; Meng HAN ; Qian XU
Chinese Journal of Modern Nursing 2021;27(4):508-512
Objective:To explore the effect of ICX ? tablets on controlling the pollution of dental unit waterlines. Methods:From September 30, 2018 to February 23, 2019, convenience sampling was used to select dental chair unit (DCU) with the dental pulp professional brand of A-dec which was newly put into use in a stomatology hospital for numbering. Using the method of random number table, four DCUs were selected and included in this study, including two in experimental group and two incontrol group. In control group, distilled water was added into two DCUs in dependent water storage tanks. In experimental group, two DCUs independent water storage tanks were added with distilled water and ICX ? tablets. From the first day of clinical use, water samples were collected continuously for 7 days, and the ICX ? tablets group was continuously sampled for 12 weeks for bacterial culture, and the number and qualified rate of colonies were counted. Results:A total of 280 water samples were collected.The number of colonies at the water outlet of the new DCU that used distilled water added with ICX ? tablets as dental unit waterlines was lower than that of distilled water group from the first day, and the difference was statistically significant ( P=0.007) . The qualified rate of colony number at the water outlet of the new DCU that used distilled water added with ICX ? tablets as dental unit waterlines was higher than that of distilled water group from the second day, and the difference was also statistically significant ( P=0.007) . Conclusions:ICX ? tablets can effectively control the pollution of dental unit waterlines and can keep the number of colonies in dental unit waterlines at a low level for a long time, but it still needs to be combined with regular monitoring and enhanced disinfection.